Director, Commercialization Partnerships Operations
Revolution Medicines
Summary
The Director, Commercialization Partnerships and Operations serves as the primary operational and partnership role at RevMed headquarters supporting the Senior Director, Commercialization Partnerships and Operations. This role is responsible for driving operational and partnership excellence, governance structure, financial tracking, and cross-functional alignment across select regional commercialization partners and territory-specific distributors. This role will also partner with regional commercial heads to support relationship management and commercial readiness across the same distribution partner(s). By serving as the central HQ liaison, this role ensures seamless coordination between RevMed's internal functional teams (Supply Chain, Regulatory, Quality, Medical Affairs, Finance) and external partners including regional commercial and distribution partners to achieve commercial readiness, regulatory/MAA approval, compliant named-patient access programs, and reliable product supply for a select region.
Job description
The Opportunity
The Director, Commercialization Partnerships and Operations serves as the primary operational and partnership role at RevMed headquarters supporting the Senior Director, Commercialization Partnerships and Operations. This role is responsible for driving operational and partnership excellence, governance structure, financial tracking, and cross-functional alignment across select regional commercialization partners and territory-specific distributors. This role will also partner with regional commercial heads to support relationship management and commercial readiness across the same distribution partner(s). By serving as the central HQ liaison, this role ensures seamless coordination between RevMed's internal functional teams (Supply Chain, Regulatory, Quality, Medical Affairs, Finance) and external partners including regional commercial and distribution partners to achieve commercial readiness, regulatory/MAA approval, compliant named-patient access programs, and reliable product supply for a select region.
Core Responsibilities & Scope
Key Performance Indicators (KPIs) & Governance Framework
- Establish, standardize, and monitor a unified commercial and operational KPI framework across select region/partner.
- Commercial & Non-Commercial KPIs: Forecast/order accuracy, market access, medical information metrics, performance to volume targets, order-to-cash cycle times, stockout frequency, inventory buffer levels, and lead-time adherence.
- Regulatory & Quality KPIs: Variances/amendment submission timelines, adherence to quality and PV agreements.
- Operationalize joint governance bodies (e.g., Joint Steering Committees [JSC], Joint Commercial Committees [JCC], and Joint Operations Committees [JOC]) and joint pricing decisions.
- Define escalation pathways, charter guidelines, voting rights, and decision-making matrices (RevMed vs. Partner/Distributor) across commercial, pricing, regulatory, and supply chain domains.
Financial Reporting & Revenue Reconciliation
- Partner with RevMed HQ Finance and Partner Commercial Operations to track, report, and analyze quarterly commercial revenue, transfer pricing, and royalty/profit-share milestones.
- Reconcile financial tracking on quarterly basis as necessary.
- Lead the quarterly financial reconciliation process across partners based on contracted KPIs, volume tiers, milestone achievements, and operational claw backs or bonuses.
- Maintain real-time executive dashboards reporting financial performance, sales volume, inventory valuation, and partner margin compliance.
Required Skills, Experience and Education
- Education: B.S./B.A. in Business, Life Sciences, Supply Chain, or Finance (MBA or advanced degree preferred).
- Experience: 8–12+ years of experience in the biopharmaceutical industry, with direct experience in Alliance Management, Commercial Operations, Strategic Account Operations, or Global Program Management.
- Cross-Functional Expertise: Proven track record bridging commercial activities with technical/operations functions (Supply Chain, Quality/CMC, Regulatory, Medical Affairs, Finance).
- Negotiation Experience: Demonstrated success developing, negotiating, and operationalizing licensing, distribution, commercialization or alliance agreements.
- Geographic & Regional Knowledge: Solid understanding of regional pharmaceutical markets, regulatory environments (regional & national competent authorities), pricing & reimbursement dynamics, and distribution models (direct vs. distributor/partner).
- Travel: Ability to travel up to 30%. Hybrid role, at minimum 2-3 days in office at Redwood City headquarters.
Preferred Skills
- Oncology development, supply chain, and commercialization experience.
- Prior experience in a smaller, rapidly growing biotech or pharmaceutical company.
Requirements
- B.S./B.A. in Business, Life Sciences, Supply Chain, or Finance
- 8–12+ years of experience in the biopharmaceutical industry
- Direct experience in Alliance Management, Commercial Operations, Strategic Account Operations, or Global Program Management
- Proven track record bridging commercial activities with technical/operations functions (Supply Chain, Quality/CMC, Regulatory, Medical Affairs, Finance)
- Demonstrated success developing, negotiating, and operationalizing licensing, distribution, commercialization or alliance agreements
- Solid understanding of regional pharmaceutical markets, regulatory environments, pricing & reimbursement dynamics, and distribution models
- Ability to travel up to 30%
- Hybrid role, at minimum 2-3 days in office at Redwood City headquarters
Benefits
- Competitive cash compensation
- Equity awards
- Learning and development opportunities
- Strong benefits
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.